The helix-loop-helix protein Id2 is expressed differentially and induced by myc in T-cell lymphomas

Cancer

Volumn 112, Issue 3, 2008, Pages 552-561

  Cotta, Claudiu V ^a   Leventaki, Vasiliki ^a   Atsaves, Vassilis ^a   Vidaki, Athina ^a   Schlette, Ellen ^a   Jones, Dan ^a   Medeiros, L Jeffrey ^a   Rassidakis, George Z ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Inhibitor of DNA binding 2; Myc; Non Hodgkin lymphoma; T cell

Indexed keywords

ADENOVIRUS VECTOR; GREEN FLUORESCENT PROTEIN; HELIX LOOP HELIX PROTEIN; INHIBITOR OF DIFFERENTIATION 2; MESSENGER RNA; MYC PROTEIN;

ARTICLE; CANCER CELL CULTURE; CELL LINE; CELL STRAIN HEK293; CONCENTRATION RESPONSE; ENTEROPATHY; GENE; HUMAN; ID2 GENE; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; NATURAL KILLER T CELL; PRIORITY JOURNAL; PROLYMPHOCYTIC LEUKEMIA; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T CELL LYMPHOMA; TRANSCRIPTION INITIATION; UPREGULATION; WESTERN BLOTTING;

CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HODGKIN DISEASE; HUMANS; INHIBITOR OF DIFFERENTIATION PROTEIN 2; LYMPHOMA, LARGE-CELL, ANAPLASTIC; LYMPHOMA, NON-HODGKIN; LYMPHOMA, T-CELL; LYMPHOMATOID PAPULOSIS; PROTO-ONCOGENE PROTEINS C-MYC; RNA, MESSENGER; SKIN NEOPLASMS; UP-REGULATION;

EID: 38749093745     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.23196     Document Type: Article

References (39)

1. Quong MW, Romanow WJ, Murre C. E protein function in lymphocyte development. Annu Rev Immunol. 2002;20:301-322.
2. Perk J, Iavarone A, Benezra R. Id family of helix-loop-helix proteins in cancer. Nat Rev Cancer. 2005;5:603-614.
3. Kurooka H, Yokota Y. Nucleo-cytoplasmic shuttling of Id2, a negative regulator of basic helix-loop-helix transcription factors. J Biol Chem. 2005;280:4313-4320.
4. Yokota Y, Mansouri A, Mori S, et al. Development of peripheral lymphoid organs and natural killer cells depends on the helix-loop-helix inhibitor Id2. Nature. 1999;397:702-706.
5. Iavarone A, King ER, Dai XM, Leone G, Stanley ER, Lasorella A. Retinoblastoma promotes definitive erythropoiesis by repressing Id2 in fetal liver macrophages. Nature. 2004;432:1040-1045.
6. Hacker C, Kirsch RD, Ju XS, et al. Transcriptional profiling identifies Id2 function in dendritic cell development. Nat Immunol. 2003;4:380-386.
7. Heinz LX, Platzer B, Reisner PM, et al. Differential involvement of PU.1 and Id2 downstream of TGF-beta1 during Langerhans-cell commitment. Blood. 2006;107:1445-1453.
8. Buitenhuis M, van Deutekom HW, Verhagen LP, et al. Differential regulation of granulopoiesis by the basic helix-loop-helix transcriptional inhibitors Id1 and Id2. Blood. 2005;105:4272-4281.
9. Lee J, Kim K, Kim JH, et al. Id helix-loop-helix proteins negatively regulate TRANCE-mediated osteoclast differentiation. Blood. 2006;107:2686-2693.
10. Biederer CH, Ries SJ, Moser M, et al. The basic helix-loop-helix transcription factors myogenin and Id2 mediate specific induction of caveolin-3 gene expression during embryonic development. J Biol Chem. 2000;275:26245-26251.
11. Hua H, Zhang YQ, Arnaud-Dabernat S, et al. BMP4 regulates pancreatic progenitor cell expansion through ID2. J Biol Chem. 2006;281:13574-13580.
12. Lasorella A, Iavarone A. The protein ENH is a cytoplasmic sequestration factor for Id2 in normal and tumor cells from the nervous system. Proc Natl Acad Sci USA. 2006;103:4976-4981.
13. Gonda H, Sugai M, Nambu Y, et al. The balance between Pax5 and Id2 activities is the key to AID gene expression. J Exp Med. 2003;198:1427-1437.
14. Oppezzo R Dumas G, Lalanne AI, et al. Different isoforms of BSAP regulate expression of AID in normal and chronic lymphocytic leukemia B cells. Blood. 2005;105:2495-2503.
15. Lasorella A, Iavarone A, Israel MA. Id2 specifically alters regulation of the cell cycle by tumor suppressor proteins. Mol Cell Biol. 1996;16:2570-2578.
16. Lasorella A, Rothschild G, Yokota Y, Russell RG, Iavarone A. Id2 mediates tumor initiation, proliferation, and angiogenesis in Rb mutant mice. Mol Cell Biol. 2005;25:3563-3574.
17. Nigten J, Breems-de Ridder MC, Erpelinck-Verschueren CA, et al. ID1 and ID2 are retinoic acid responsive genes and induce a G0/G1 accumulation in acute promyelocytic leukemia cells. Leukemia. 2005;19:799-805.
18. Cannarile MA, Lind NA, Rivera R, et al. Transcriptional regulator Id2 mediates CD8(+) T cell immunity. Nat Immunol. 2006;7:1317-1325.
19. Fukuma M, Okita H, Hata J, Umezawa A. Upregulation of Id2, an oncogenic helix-loop-helix protein, is mediated by the chimeric EWS/ets protein in Ewing sarcoma. Oncogene. 2003;22:1-9.
20. Sato Y, Kobayashi Y, Sasaki H, et al. Expression of Id2 mRNA in neuroblastoma and normal ganglion. Eur J Surg Oncol. 2003;29:284-287.
21. Nilsson JA, Nilsson LM, Keller U, Yokota Y, Boyd K, Cleveland JL. Id2 is dispensable for myc-induced lymphomagenesis. Cancer Res. 2004;64:7296-7301.
22. Alaminos M, Gerald WL, Cheung NK. Prognostic value of MYCN and ID2 overexpression in neuroblastoma. Pediatr Blood Cancer. 2005;45:909-915.
23. Gebauer S, Yu AL, Omura-Minamisawa M, Batova A, Diccianni MB. Expression profiles and clinical relationships of ID2, CDKN1B, and CDKN2A in primary neuroblastoma. Genes Chromosomes Cancer. 2004;41:297-308.
24. Asirvatham AJ, Schmidt MA, Chaudhary J. Non-redundant inhibitor of differentiation (Id) gene expression and function in human prostate epithelial cells. Prostate. 2006;66:921-935.
25. Coppe JP, Itahana Y, Moore DH, Bennington JL, Desprez PY. Id-1 and Id-2 proteins as molecular markers for human prostate cancer progression. Clin Cancer Res. 2004;10:2044-2051.
26. Fernandez-Garcia NI, Palmer HG, Garcia M, et al. 1alpha,25- Dihydroxyvitamin D3 regulates the expression of Id1 and Id2 genes and the angiogenic phenotype of human colon carcinoma cells. Oncogene. 2005;24:6533-6544.
27. Kim NS, Kim HJ, Koo BK, et al. Receptor activator of NF-kappaB ligand regulates the proliferation of mammary epithelial cells via Id2. Mol Cell Biol. 2006;26:1002-1013.
28. Russell RG, Lasorella A, Dettin LE, Iavarone A. Id2 drives differentiation and suppresses tumor formation in the intestinal epithelium. Cancer Res. 2004;64:7220-7225.
29. Stighall M, Manetopoulos C, Axelson H, Landberg G. High ID2 protein expression correlates with a favourable prognosis in patients with primary breast cancer and reduces cellular invasiveness of breast cancer cells. Int J Cancer. 2005;115:403-411.
30. Mathas S, Janz M, Hummel F, et al. Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma. Nat Immunol. 2006;7:207-215.
31. Renne C, Martin-Subero JI, Eickernjager M, et al. Aberrant expression of ID2, a suppressor of B-cell-specific gene expression, in Hodgkin's lymphoma. Am J Pathol. 2006;169:655-664.
32. Vega F, Medeiros LJ, Leventaki V, et al. Activation of mammalian target of rapamycin signaling pathway contributes to tumor cell survival in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma. Cancer Res. 2006;66:6589-6597.
33. Jaffe ES, Harris NL, Stein H, Vardiman JW. Pathology and genetics of tumors of haematopoietic and lymphoid tissues. Lyon, France: IARC Press; 2001.
34. Rassidakis GZ, Jones D, Thomaides A, et al. Apoptotic rate in peripheral T-cell lymphomas. A study using a tissue microarray with validation on full tissue sections. Am J Clin Pathol. 2002;118:328-334.
35. Rassidakis GZ, Sarris AH, Herling M, et al. Differential expression of BCL-2 family proteins in ALK-positive and ALK-negative anaplastic large cell lymphoma of T/null-cell lineage. Am J Pathol. 2001;159:527-535.
36. Raetz EA, Perkins SL, Carlson MA, Schooler KP, Carroll WL, Virshup DM. The nucleophosmin-anaplastic lymphoma kinase fusion protein induces c-Myc expression in pediatric anaplastic large cell lymphomas. Am J Pathol. 2002;161:875-883.
37. Kim JK, Takeuchi M, Yokota Y. Impairment of intestinal intraepithelial lymphocytes in Id2 deficient mice. Gut. 2004;53:480-486.
38. Lasorella A, Noseda M, Beyna M, Yokota Y, Iavarone A. Id2 is a retinoblastoma protein target and mediates signalling by Myc oncoproteins. Nature. 2000;407:592-598.
39. Inghirami G, Macri L, Cesarman E, Chadburn A, Zhong J, Knowles DM. Molecular characterization of CD30+ anaplastic large-cell lymphoma: high frequency of c-myc proto-oncogene activation. Blood. 1994;83:3581-3590.